Loading...
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody
T-cell expression of programmed death receptor-1 (PD-1) down-regulates the immune response against malignancy by interacting with cognate ligands (eg, PD-L1) on tumor cells; however, little is known regarding PD-1 and natural killer (NK) cells. NK cells exert cytotoxicity against multiple myeloma (M...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
American Society of Hematology
2010
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3490105/ https://ncbi.nlm.nih.gov/pubmed/20460501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-02-271874 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|